These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12858029)

  • 1. [In vitro and in vivo effects of cefodizime and ceftriaxone on oxygen-dependent killing of neutrophils of elderly patients with exacerbation of chronic bronchitis].
    Papa L; Guida G; Morano CM; Loiacono G; Lopiano S; Perrone A
    Infez Med; 1996; 4(4):228-33. PubMed ID: 12858029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open, controlled, randomized study on the efficacy and safety of cefodizime single daily dose versus two daily doses and versus ceftriaxone single daily dose in patients with acute purulent bronchitis and acute purulent exacerbation of chronic bronchitis.
    Zanussi C; Cocuzza G
    J Chemother; 1995 Dec; 7(6):535-42. PubMed ID: 8667039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
    Blandino G; Milazzo I; Musumeci R; Nicolosi VM; Speciale A; Nicoletti G
    J Chemother; 2000 Dec; 12(6):503-8. PubMed ID: 11154034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of some antibiotics on polymorphonuclear leukocyte functions of elderly patients in vitro before and after zinc supplementation.
    Gürer US; Göçer P; Erçağ E; Erten N; Rayaman E; Gürbüz B; Uzer A; Karan A; Cevikbaş A
    Int Immunopharmacol; 2006 May; 6(5):808-16. PubMed ID: 16546712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
    McCafferty AC; McGregor E; Jones M; Henderson IS; Cree IA
    Int J Clin Lab Res; 1996; 26(4):229-35. PubMed ID: 9007612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity.
    Labro MT; Amit N; Babin-Chevaye C; Hakim J
    J Antimicrob Chemother; 1987 Mar; 19(3):331-41. PubMed ID: 3032885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefodizime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Barradell LB; Brogden RN
    Drugs; 1992 Nov; 44(5):800-34. PubMed ID: 1280568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone.
    Pacheco Y; Hosni R; Dagrosa EE; Gormand F; Guibert B; Chabannes B; Lagarde M; Perrin-Fayolle M
    Arzneimittelforschung; 1994 Apr; 44(4):559-63. PubMed ID: 8011012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of sub-minimum inhibitory concentrations of cefodizime on the phagocytosis, intracellular killing and oxidative bursts of human polymorphonuclear leukocytes.
    Braga PC; Dal Sasso M; Mancini L; Sala MT
    Chemotherapy; 1999; 45(3):166-74. PubMed ID: 10224338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefodizime once daily in the treatment of lower respiratory tract infections.
    Piovano CF; Palombini BC; Dagrosa EE; Mendoza F; Facco EB
    Arzneimittelforschung; 1997 May; 47(5):674-7. PubMed ID: 9205786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cefodizime (HR 221) on immunological defects induced by surgical stress.
    Auteri A; Pasqui AL; Bruni F; Saletti M; Mazza S; Di Renzo M; Maggiore D; Di Perri T
    Drugs Exp Clin Res; 1991; 17(12):555-61. PubMed ID: 1841048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors.
    Shin WS; Min CK; Kim YR; Yoo JH; Kang MW
    J Antimicrob Chemother; 1996 Jan; 37(1):93-103. PubMed ID: 8647779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic mobility of cefodizime-treated Staphylococcus aureus and chemiluminescence of human polymorphonuclear leucocytes.
    Muratsugu M; Tomonaga M; Miyake Y; Terayama K; Ishida N
    J Antimicrob Chemother; 1991 Dec; 28(6):887-96. PubMed ID: 1816185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of cefodizime on chemotaxis and the respiratory burst in neutrophils from diabetics.
    Shaio MF; Chang FY
    J Antimicrob Chemother; 1990 Jul; 26(1):55-9. PubMed ID: 2211447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cefodizime on peritoneal mononuclear- and polymorphonuclear-cell chemotaxis.
    Ustün H; Ersoy FF; Sezer T; Ozcan S; Bozcuk H; Yegin O; Balci M; Süleymanlar G; Yakupoglu G
    Adv Perit Dial; 1998; 14():154-7. PubMed ID: 10649715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.
    Meyer B; Traunmueller F; Bojic A; Locker G; Schmid R; Winkler S; Thalhammer F
    Int J Antimicrob Agents; 2006 Apr; 27(4):335-8. PubMed ID: 16563704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Microbiological aspects of antibiotics with immunomodulating action].
    Schito GC; Debbia EA; Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A
    J Chemother; 1994 Aug; 6 Suppl 3():19-22. PubMed ID: 7861204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of cefodizime and other antibiotics against pathogens recently isolated in Italy.
    Nicoletti G; Blandino G; Cocuzza G; Dainelli B; Maida A; Debbia E; Schito G
    Chemotherapy; 1996; 42(2):100-6. PubMed ID: 8697884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime.
    Nomura S; Nagayama A
    Chemotherapy; 1995; 41(3):178-86. PubMed ID: 7656663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
    Marton A; Major P
    Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.